BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30033600)

  • 41. UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.
    Granovsky M; Bielfeldt T; Peters S; Paulsen H; Meldal M; Brockhausen J; Brockhausen I
    Eur J Biochem; 1994 May; 221(3):1039-46. PubMed ID: 8181460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly Efficient Analysis of Glycoprotein Sialylation in Human Serum by Simultaneous Quantification of Glycosites and Site-Specific Glycoforms.
    Qin H; Dong X; Mao J; Chen Y; Dong M; Wang L; Guo Z; Liang X; Ye M
    J Proteome Res; 2019 Sep; 18(9):3439-3446. PubMed ID: 31380653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a data independent acquisition mass spectrometry workflow to enable glycopeptide analysis without predefined glycan compositional knowledge.
    Lin CH; Krisp C; Packer NH; Molloy MP
    J Proteomics; 2018 Feb; 172():68-75. PubMed ID: 29069609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Hanganutziu-Deicher antigens in O-glycans from pig heart tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Jeong HJ; Adhya M; Park HM; Kim YG; Kim BG
    Xenotransplantation; 2013; 20(6):407-17. PubMed ID: 23855430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptides.
    Chen M; Shi X; Duke RM; Ruse CI; Dai N; Taron CH; Samuelson JC
    Nat Commun; 2017 May; 8():15487. PubMed ID: 28534482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of peeling during the release of O-glycans by hydrazinolysis.
    Kozak RP; Royle L; Gardner RA; Fernandes DL; Wuhrer M
    Anal Biochem; 2012 Apr; 423(1):119-28. PubMed ID: 22306471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical de-O-glycosylation of glycoproteins for applications in LC-based proteomics.
    Hanisch FG
    Methods Mol Biol; 2011; 753():323-33. PubMed ID: 21604133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual-Probe Approach for Mass Spectrometric Quantification of MUC1-Specific Terminal Gal/GalNAc
    Sun B; Xu F; Zhang Y; Hu Y; Chen Y
    Anal Chem; 2020 Jun; 92(12):8340-8349. PubMed ID: 32502344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of hydrazide-functionalized hydrophilic polymer hybrid graphene oxide for highly efficient N-glycopeptide enrichment and identification by mass spectrometry.
    Bai H; Pan Y; Guo C; Zhao X; Shen B; Wang X; Liu Z; Cheng Y; Qin W; Qian X
    Talanta; 2017 Aug; 171():124-131. PubMed ID: 28551118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based Glycoproteomics.
    Hinneburg H; Stavenhagen K; Schweiger-Hufnagel U; Pengelley S; Jabs W; Seeberger PH; Silva DV; Wuhrer M; Kolarich D
    J Am Soc Mass Spectrom; 2016 Mar; 27(3):507-19. PubMed ID: 26729457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Location, location, location: new insights into O-GalNAc protein glycosylation.
    Gill DJ; Clausen H; Bard F
    Trends Cell Biol; 2011 Mar; 21(3):149-58. PubMed ID: 21145746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Click-iG: Simultaneous Enrichment and Profiling of Intact N-linked, O-GalNAc, and O-GlcNAcylated Glycopeptides.
    Liu J; Cheng B; Fan X; Zhou X; Wang J; Zhou W; Li H; Zeng W; Yang P; Chen X
    Angew Chem Int Ed Engl; 2023 Sep; 62(36):e202303410. PubMed ID: 37431278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel core 1 O-linked glycan-specific binding lectin from the fruiting body of Hericium erinaceus.
    Kim S
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1528-1537. PubMed ID: 28988842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic precision labeling enables selective probing of O-linked
    Debets MF; Tastan OY; Wisnovsky SP; Malaker SA; Angelis N; Moeckl LKR; Choi J; Flynn H; Wagner LJS; Bineva-Todd G; Antonopoulos A; Cioce A; Browne WM; Li Z; Briggs DC; Douglas HL; Hess GT; Agbay AJ; Roustan C; Kjaer S; Haslam SM; Snijders AP; Bassik MC; Moerner WE; Li VSW; Bertozzi CR; Schumann B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25293-25301. PubMed ID: 32989128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
    Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly sensitive glycosylamine labelling of O-glycans using non-reductive β-elimination.
    Furuki K; Toyo'oka T; Ban K
    Anal Bioanal Chem; 2017 Mar; 409(9):2269-2283. PubMed ID: 28091715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. O-glycan recognition and function in mice and human cancers.
    Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
    Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Wisteria floribunda agglutinin affinity chromatography in the structural analysis of the bovine lactoferrin N-linked glycosylation.
    van Leeuwen SS; Schoemaker RJ; Timmer CJ; Kamerling JP; Dijkhuizen L
    Biochim Biophys Acta; 2012 Sep; 1820(9):1444-55. PubMed ID: 22245701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycosylation analysis of two cysteine proteinase inhibitors from Atlantic salmon skin: di-O-acetylated sialic acids are the major sialic acid species on N-glycans.
    Ylönen A; Kalkkinen N; Saarinen J; Bøgwald J; Helin J
    Glycobiology; 2001 Jul; 11(7):523-31. PubMed ID: 11447131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. O-linked N-acetylgalactosamine modification is present on the tumor suppressor p53.
    Xu Z; Ku X; Tomioka A; Xie W; Liang T; Zou X; Cui Y; Sato T; Kaji H; Narimatsu H; Yan W; Zhang Y
    Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129635. PubMed ID: 32417172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.